ClinicalTrials.govpublic full text
Efficacy and Safety of CDP6038 in Patients With Rheumatoid Arthritis With an Unsuccessful Response to Anti-Tumor Necrosis Factor (Anti-TNF) Therapy
rheumatoid arthritis, cdp6038, interleukin-6, tocilizumab, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 911434
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.